Monitoring and Population HealthResults, Monitoring and Recalls

Monitoring that follows through to evidence.

A medicine needs blood tests; Reedley links each result to its request and monitoring requirement, keeps follow-up open, and is designed to close it only when a clinician’s review is recorded (in the development build the loop closes when the result is received).

Illustrative demonstration · intended workflow

Interactive demonstration

Synthetic patient · pause, step and replay at any point

Results and monitoring: lithium

Synthetic patient
Susan GREAVESNHS 999 000 2045Born 11 Mar 1968 · 58 y · Female
Susan GREAVES NHS 999 000 2045

Born 11 Mar 1968 · 58 y · Female

Step 1 of 6 · Expected monitoring

  1. Expected monitoring
  2. Latest available results In the development build
  3. Missing evidence
  4. Review requirement
  5. Recall and follow-up
  6. Verified by results
Record as at 20 Oct 2026, 09:00Record as at 29 Oct 2026, 08:52Record as at 30 Oct 2026, 16:20

Priadel 400 mg modified-release tablets (lithium carbonate) · two at nightRepeat entry · 8 Oct 2026

Lithium is recorded by brand; SPS notes that preparations differ in bioavailability. SPS · Prescribing by brand

Step 1 · Expected monitoring

Expected monitoring

A draft, unsigned rule for lithium, shown with its sources as intended design, sets what is expected and when. The development build’s draft rule differs: different tests and intervals, and no citations.

Lithium monitoring (draft) v0.3-draft

Draft · unsigned · no named clinical owner · needs clinical sign-off before use

Draft practice rule (unsigned, no named owner): serum lithium, U&E with calcium, eGFR, thyroid function and weight or BMI every 6 months after the first year, or lithium every 3 months for the groups in NICE CG185 1.10.20. For this patient, 6-monthly monitoring was recorded by Dr H. MARSH on 14 Apr 2026.

Lithium review · 14 Apr 2026NICE · 1.10.20NICE · 1.10.21

What the draft rule expects
TestInterval in the draft ruleSource
Serum lithium (12-hour post-dose sample)Every 6 months after the first year; every 3 months for people in any of these groups (NICE CG185 1.10.20; a clinician records which applies):
  • older people
  • people taking drugs that interact with lithium
  • people who are at risk of impaired renal or thyroid function, raised calcium levels or other complications
  • people who have poor symptom control
  • people with poor adherence
  • people whose last plasma lithium level was 0.8 mmol per litre or higher
NICE · 1.10.20SPS · After started or dose changed
U&E including calcium, eGFREvery 6 months; more often in the circumstances NICE CG185 1.10.21 lists (applied by a clinician)NICE · 1.10.21
Thyroid functionEvery 6 months; more often in the circumstances NICE CG185 1.10.21 lists (applied by a clinician)NICE · 1.10.21
Weight or BMIEvery 6 monthsNICE · 1.10.21

Last practice bloods 14 Apr 2026Due by 14 Oct 2026 (6-monthly, as recorded 14 Apr 2026)

Reedley applies the interval a clinician recorded; it does not assess which group applies.

Step 2 · Latest available results In the development build

As reported by the laboratory · no interpretation

The latest results are shown as the laboratory reported them, with the laboratory’s own flags only.

Step 3 · Missing evidence

Missing evidence

What the rule expects and the record does not show, with the limit of an incomplete feed stated.

  • Not found in the available recordNo lithium level found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
  • Not found in the available recordNo thyroid function result found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
  • Not found in the available recordNo calcium result found in the available record since 14 Apr 2026.Results received 14 Apr 2026 16:02
  • An incomplete record or results feed cannot prove a test was not done; the test may have been done elsewhere.

Step 4 · Review requirement

Review requirement

Each received result goes to a clinician through the practice’s own results workflow; this item stays open until a review is recorded.

  • Lithium monitoring: serum lithium (draft 6-monthly rule)

    Admin teamDue by 14 Oct 2026Assigned

    Verified only by A serum lithium result received in the record, then a review by a named clinician. Invitation, booking and request do not verify.

  • Lithium monitoring: adjusted calcium (draft 6-monthly rule)

    Admin teamDue by 14 Oct 2026Assigned

    Verified only by An adjusted calcium result received in the record, then a review by a named clinician.

  • Lithium monitoring: thyroid function (draft 6-monthly rule)

    Admin teamDue by 14 Oct 2026Assigned

    Verified only by A thyroid function result received in the record, then a review by a named clinician.

  • Lithium monitoring: weight or BMI (draft 6-monthly rule)

    Practice nurseDue by 14 Oct 2026Assigned

    Verified only by A weight or BMI recorded in the clinical record.

Step 5 · Recall and follow-up

Recall and follow-up

An invitation, a booking and a request are recorded; none of them verifies the test.

  1. ActionedInvitation sent21 Oct, 10:15Does not verifyInvitation sent 21 Oct 2026 (sent is not read).Invitation sent · 21 Oct 2026
  2. ActionedBooked23 Oct, 14:30Does not verifyBooked by the patient on 23 Oct 2026 for 29 Oct 2026 (booked is not attended).Booked · 23 Oct 2026
  3. ActionedRequested29 Oct, 08:52Does not verifyTests requested 29 Oct 2026 (requested is not resulted).Requested · 29 Oct 2026
  4. VerifiedResult receivedNot in the record yetVerifies
  5. ClosedReviewed and filedNot in the record yetCloses

PlannedCreating the recall in the practice’s own system

Step 6 · Verified by results

Verified by results

Results received on 30 Oct verify the lithium level and adjusted calcium; the review by a named clinician closes them. Thyroid function stays open.

  1. ActionedInvitation sent21 Oct, 10:15Does not verifyInvitation sent 21 Oct 2026 (sent is not read).Invitation sent · 21 Oct 2026
  2. ActionedBooked23 Oct, 14:30Does not verifyBooked by the patient on 23 Oct 2026 for 29 Oct 2026 (booked is not attended).Booked · 23 Oct 2026
  3. ActionedRequested29 Oct, 08:52Does not verifyTests requested 29 Oct 2026 (requested is not resulted).Requested · 29 Oct 2026
  4. VerifiedResult received30 Oct, 11:02VerifiesSerum lithium, U&E, calcium and eGFR received 30 Oct 2026 11:02.Results received 30 Oct 2026 11:02
  5. ClosedReviewed and filed30 Oct, 16:20ClosesReviewed and filed by Dr H. MARSH (synthetic), 30 Oct 2026 16:20.Result review · 30 Oct 2026
  • ClosedLithium monitoring: serum lithium (draft 6-monthly rule)Verified 30 Oct, 11:02 (Result received in the record) · Closed 30 Oct, 16:20 (Reviewed and filed by Dr H. MARSH (synthetic))
  • ClosedLithium monitoring: adjusted calcium (draft 6-monthly rule)Verified 30 Oct, 11:02 · Closed 30 Oct, 16:20
  • ClosedLithium monitoring: weight or BMI (draft 6-monthly rule)Verified 29 Oct, 09:05 (Weight recorded in a consultation) · Closed 29 Oct, 09:05Observation · 29 Oct 2026
  • ActionedLithium monitoring: thyroid function (draft 6-monthly rule)Requested 29 Oct 2026; no thyroid function result found in the available record since 14 Apr 2026. Requested is not resulted.

Verification from the practice’s live results depends on access to the clinical system that the practice and its system supplier would have to grant; here it is simulated.

Synthetic record

Oldest first · entries arrive as time moves on

Problem

Bipolar affective disorder · since 2019

Results received 14 Apr 2026 16:02

Serum lithium 0.62 mmol/L (laboratory reference 0.4–1.0) · Sodium 139 mmol/L · Potassium 4.3 mmol/L · Creatinine 78 µmol/L · eGFR 74 mL/min/1.73m2 · Adjusted calcium 2.38 mmol/L · TSH 2.1 mU/L · No laboratory flags

Observation

Weight 71 kg · BMI 26.1

Lithium review · Dr Helen MARSH, GP (synthetic)

Lithium review: 6-monthly monitoring agreed; none of the NICE 3-monthly groups recorded. Lithium started 2019 (community mental health team). (Simulated)

Results received 2 Sep 2026 12:40

Sodium 140 mmol/L · Potassium 4.1 mmol/L · Creatinine 81 µmol/L · eGFR 71 mL/min/1.73m2 · No laboratory flags

Repeat entry

Priadel 400 mg modified-release tablets (lithium carbonate) · Two at night · Repeat · Last issued 8 Oct 2026

Invitation sent

Invitation sent: lithium monitoring blood test and weight check. (Simulated)

Booked

Phlebotomy appointment booked by the patient for 29 Oct 2026 08:50. (Simulated)

Requested

Requested: serum lithium (12-hour post-dose sample), U&E, adjusted calcium, eGFR, thyroid function. (Simulated)

Observation

Weight 72 kg · BMI 26.4

Results received 30 Oct 2026 11:02

Serum lithium 0.66 mmol/L (laboratory reference 0.4–1.0) · Sodium 138 mmol/L · Potassium 4.2 mmol/L · Creatinine 80 µmol/L · eGFR 72 mL/min/1.73m2 · Adjusted calcium 2.40 mmol/L · No laboratory flags · Thyroid function: not reported on this request

Result review · Dr Helen MARSH, GP (synthetic)

Lithium monitoring results of 30 Oct 2026 reviewed and filed. (Simulated)

Guidance the draft rule cites 4 passages · NICE and SPS

Guidance the draft rule cites

NICE

After the first year, measure plasma lithium levels every 6 months, or every 3 months for people in any of the following groups:

Open the source · opened 13 Nov 2026

NICE

Measure the person's weight or BMI and arrange tests for urea and electrolytes including calcium, estimated glomerular filtration rate (eGFR) and thyroid function every 6 months, and more often if there is evidence of impaired renal or thyroid function, raised calcium levels or an increase in mood symptoms that might be related to impaired thyroid function.

Open the source · opened 13 Nov 2026

NHS Specialist Pharmacy Service (last updated 6 Dec 2024)

Preparations vary widely in bioavailability and therefore should be prescribed by brand.

Open the source · opened 13 Nov 2026

NHS Specialist Pharmacy Service (last updated 6 Dec 2024)

take sample just prior to time of next dose (i.e. trough level 12 hours following last dose)

Open the source · opened 13 Nov 2026

Synthetic demonstration · fictional patient, clinicians and organisations · NHS number in the 999 test range · Not connected to any clinical system · Nothing is written to a medication record

Illustrative demonstration · intended workflow, except steps marked In the development build · Scripted reconstruction: the development build itself is not running on this page.

  • Results shown as the laboratory reported them, linked to the monitoring requirement.
  • Missing results stay visible, with what was searched.
  • Follow-up and recall steps show what happened, and what has not yet.

From what arrives to what you decide

  1. What entersA medicine that needs blood tests
  2. What Reedley preparesEach result linked to its request and monitoring requirement; follow-up kept open
  3. What the clinician decidesA clinician reviews; follow-up is designed to close only when that review is recorded

What it does not do · what exists today

  • Reedley does not interpret results or decide which results a clinician sees: the practice’s own results workflow is unchanged.
  • In the development build, a result received in the record is shown as reported and linked to the monitoring requirement it satisfies, and draft-rule monitoring work is created. There, a follow-up loop closes when the result is received, without waiting for a recorded review. Recall creation and invitations are planned.
  • Monitoring rules in the development build are drafts with no clinical owner and no source citations, and they differ from national (SPS) guidance; the cited rule in the demonstration is illustrative.

Every patient shown is synthetic. No integration with a clinical system is claimed, and no clinician has yet used Reedley in practice. Safety and governance

See it with your own work in mind.

Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.